| Business Summary | | Arrhythmia
Research
Technology,
Inc.
(ART)
sells
and
licenses
computerized
medical
instruments
that
acquire
data
and
analyze
electrical
impulses
of
the
heart
to
detect
and
aid
in
the
treatment
of
potentially
lethal
arrhythmias.
ART's
product
line
includes
signal-averaging
electrocardiographic
(SAECG)
equipment
comprised
of
the
Tri-Pac,
the
1200
EPX,
the
LP-Pac
Q
and
the
Predictor
7.
ART's
wholly
owned
subsidiary,
Micron
Products,
Inc.,
is
a
manufacturer
and
distributor
of
silver/silver
chloride-plated
sensor
elements
(sensors)
used
in
the
manufacture
of
disposable
electrodes
constituting
a
part
of
ECG
diagnostic
and
monitoring
instruments.
Micron
also
acts
as
a
distributor
of
metal
snap
fasteners
(snaps),
another
component
used
in
the
manufacture
of
disposable
electrodes.
In
addition,
Micron
manufactures
and
leases
electrode
assembly
machines,
which
it
manufactures
and
sells
or
leases
to
its
sensor
and
snap
customers. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | HRT
markets
and
manufactures
computerized
medical
instruments
which
acquire
data
and
analyze
electrical
impulses
of
the
heart
to
detect
and
aid
the
treatment
of
potentially
lethal
arrhythmias.
For
the
six
months
ended
6/30/01,
net
sales
fell
33%
to
$3.6
million.
Net
income
fell
82%
to
$137
thousand.
Revenues
reflect
the
absence
of
a
$1
million
special
commission
income
and
lower
sales
of
snaps.
Lower
income
also
reflects
higher
research
and
development
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY1999 Pay | |
| E. Marinos, 58 Chairman | -- | Anthony Cetrone, 71 CEO | $103K | Nancy Arnold, 52 Pres,
Gen. Counsel | 83K | Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|